MRI Contrast Agents and Lanthanide Luminescent Materials
This community develops chemical compounds for medical imaging, focusing on gadolinium-based agents for magnetic resonance imaging and lanthanide complexes for luminescent detection.
The work centers on the synthesis and evaluation of gadolinium-based contrast agents for MRI, with significant attention to breast cancer and vessel wall imaging. A parallel strand involves europium, terbium, and other lanthanide complexes used for luminescence, circularly polarized light, and energy transfer applications. The research frequently examines the glymphatic system, cerebrospinal fluid dynamics, and brain clearance mechanisms, often using diffusion tensor imaging and deep learning for analysis. Methods include the design of new molecular structures, nanoparticle synthesis, and the assessment of agent safety and efficacy in patient populations.
The community represents 20.1% of all europium research, 16.1% of terbium research, and 14.0% of gadolinium research, with gadolinium contributing the highest paper count within this group.
The community comprises 44,077 papers, publishing primarily in the Journal of Magnetic Resonance Imaging, Inorganic Chemistry, and Radiology.
Recent work continues to explore the glymphatic system and brain clearance, alongside the development of gadolinium oxide nanoparticles and lanthanide-based luminescent materials for advanced imaging applications.